CXCR2 and colitis: It has been shown that selective blockade of IL-1R, CXCR2, CXCL1/KC, MCP-1, MIP-2, TNF-α and IL-6 significantly decreases severity of colitis and neutrophil/macrophage migration [4], [6], [23].